THEOPHYL Drug Patent Profile
✉ Email this page to a colleague
When do Theophyl patents expire, and what generic alternatives are available?
Theophyl is a drug marketed by Ortho Mcneil Pharm, Cent Pharms, Hospira, Inwood Labs, Sandoz, Kv Pharm, Scherer Rp, Alpharma Us Pharms, Cenci, Chartwell Rx, Halsey, Pharm Assoc, Precision Dose, Roxane, Taro, Wockhardt, Chartwell Molecular, Tris Pharma Inc, Able, Alembic, Amneal, Annora Pharma, Bionpharma, Glenmark Pharms Ltd, Harman Finochem, Heritage Pharma Avet, Nostrum Labs Inc, Rhodes Pharms, Strides Pharma, Teva Pharms Inc, Velzen Pharma Pvt, Zydus Lifesciences, B Braun, Baxter Hlthcare, and Hospira Inc. and is included in fifty-eight NDAs.
The generic ingredient in THEOPHYL is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Theophyl
A generic version of THEOPHYL was approved as theophylline by RHODES PHARMS on September 1st, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for THEOPHYL?
- What are the global sales for THEOPHYL?
- What is Average Wholesale Price for THEOPHYL?
Summary for THEOPHYL
| US Patents: | 0 |
| Applicants: | 35 |
| NDAs: | 58 |
| Raw Ingredient (Bulk) Api Vendors: | 171 |
| Patent Applications: | 4,007 |
| Drug Prices: | Drug price information for THEOPHYL |
| DailyMed Link: | THEOPHYL at DailyMed |
US Patents and Regulatory Information for THEOPHYL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B Braun | THEOPHYLLINE 0.04% AND DEXTROSE 5% IN PLASTIC CONTAINER | theophylline | INJECTABLE;INJECTION | 019083-001 | Nov 7, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Alembic | THEOPHYLLINE | theophylline | TABLET, EXTENDED RELEASE;ORAL | 090430-002 | Oct 27, 2010 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Roxane | THEOPHYLLINE | theophylline | SOLUTION;ORAL | 087449-001 | Sep 15, 1983 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Baxter Hlthcare | THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER | theophylline | INJECTABLE;INJECTION | 018649-002 | Jul 26, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glenmark Pharms Ltd | THEOPHYLLINE | theophylline | TABLET, EXTENDED RELEASE;ORAL | 090355-001 | Jul 13, 2010 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Nostrum Labs Inc | THEOPHYLLINE | theophylline | TABLET, EXTENDED RELEASE;ORAL | 040560-002 | Apr 21, 2006 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
